Caplin Point Laboratories Limited (CAPLIPOINT)
₹2,400
INR+2.85(+0.12%)
As of December 26, 2024 9:59:00 AMAbout Caplin Point Laboratories Limited
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
9.59
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
30.64
+13.900000000000002% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
17569.72 CrINR
Total market value of the company's outstanding shares
Employees
3406
Total number of full-time employees worldwide
CEO
NA
Chief Executive Officer of the company